{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:24:46Z","timestamp":1793982286497,"version":"4.8.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ201611652"],"award-info":[{"award-number":["GZ201611652"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ201611652"],"award-info":[{"award-number":["GZ201611652"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ201611652"],"award-info":[{"award-number":["GZ201611652"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ201611652"],"award-info":[{"award-number":["GZ201611652"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ201611652"],"award-info":[{"award-number":["GZ201611652"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ201611652"],"award-info":[{"award-number":["GZ201611652"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ201611652"],"award-info":[{"award-number":["GZ201611652"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ201611652"],"award-info":[{"award-number":["GZ201611652"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ201611652"],"award-info":[{"award-number":["GZ201611652"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ201611652"],"award-info":[{"award-number":["GZ201611652"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["GZ201611652"],"award-info":[{"award-number":["GZ201611652"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41409-026-03024-7","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:23:09Z","timestamp":1787329389000},"page":"1519-1525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants \u2013 a study from the Cell Therapy Transplant Canada\/ Australasian Leukemia Lymphoma Group Consortium"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0430-3837","authenticated-orcid":false,"given":"Irwin","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9391-4204","authenticated-orcid":false,"given":"Uday","family":"Deotare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7622-4065","authenticated-orcid":false,"given":"Mohamed","family":"Elemary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9872-2471","authenticated-orcid":false,"given":"Mahmoud","family":"Elsawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9847-6706","authenticated-orcid":false,"given":"Genevi\u00e8ve","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2020-0275","authenticated-orcid":false,"given":"David","family":"Kliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3726-8313","authenticated-orcid":false,"given":"Tony","family":"Panzarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7929-1450","authenticated-orcid":false,"given":"Nada","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-9122","authenticated-orcid":false,"given":"Jan","family":"Storek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristjan","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"3024_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","volume":"12","author":"A Bacigalupo","year":"2006","unstructured":"Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE, et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant. 2006;12:560\u20135.","journal-title":"Biol Blood Marrow Transplant"},{"key":"3024_CR2","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1016\/S2352-3026(17)30081-9","volume":"4","author":"J Finke","year":"2017","unstructured":"Finke J, Schmoor C, Bethge WA, Ottinger H, Stelljes M, Volin L, et al. Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial. Lancet Haematol. 2017;4:e293\u2013301.","journal-title":"Lancet Haematol"},{"key":"3024_CR3","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/S2352-3026(19)30220-0","volume":"7","author":"I Walker","year":"2020","unstructured":"Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, et al. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. Lancet Haematol. 2020;7:e100\u201311.","journal-title":"Lancet Haematol"},{"key":"3024_CR4","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1200\/JCO.2017.75.8177","volume":"35","author":"RJ Soiffer","year":"2017","unstructured":"Soiffer RJ, Kim HT, McGuirk J, Horwitz ME, Johnston L, Patnaik MM, et al. Prospective, randomized, double-blind, phase III clinical trial of anti\u2013T-lymphocyte globulin to assess impact on chronic graft-versus-host disease\u2013free survival in patients undergoing HLA-matched unrelated myeloablative hematopoietic cell transplantation. J Clin Oncol. 2017;35:4003\u201311.","journal-title":"J Clin Oncol"},{"key":"3024_CR5","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1200\/JCO.20.00150","volume":"38","author":"Y-J Chang","year":"2020","unstructured":"Chang Y-J, Wu D-P, Lai Y-R, Liu Q-F, Sun Y-Q, Hu J, et al. Antithymocyte globulin for matched sibling donor transplantation in patients with hematologic malignancies: a multicenter, open-label, randomized controlled study. J Clin Oncol. 2020;38:3367\u201376.","journal-title":"J Clin Oncol"},{"key":"3024_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1506002","volume":"374","author":"N Kroger","year":"2016","unstructured":"Kroger N, Solano C, Wolschke C, Bandini G, Patriarca F, Pini M, et al. Antilymphocyte globulin for prevention of chronic graft-versus-host disease. N Engl J Med. 2016;374:43\u201353.","journal-title":"N Engl J Med"},{"key":"3024_CR7","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","volume":"388","author":"J Bola\u00f1os-Meade","year":"2023","unstructured":"Bola\u00f1os-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, et al. Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis. N Engl J Med. 2023;388:2338\u201348.","journal-title":"N Engl J Med"},{"key":"3024_CR8","doi-asserted-by":"crossref","unstructured":"Curtis DJ, Patil SS, Reynolds J, Purtill D, Lewis C, Ritchie DS, et al. Graft-versus-host disease prophylaxis with cyclophosphamide and cyclosporin. N Engl J Med 2025;393:243.","DOI":"10.1056\/NEJMoa2503189"},{"key":"3024_CR9","doi-asserted-by":"crossref","unstructured":"Luznik L, Pasquini MC, Logan B, Soiffer RJ, Wu J, Devine SM, et al. Randomized phase III BMT CTN trial of calcineurin inhibitor\u2013free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies. J Clin Oncol 2021;40:356\u201368.","DOI":"10.1200\/JCO.21.02293"},{"key":"3024_CR10","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s41409-022-01754-y","volume":"57","author":"Y Zu","year":"2022","unstructured":"Zu Y, Li Z, Gui R, Liu Y, Zhang Y, Yu F, et al. Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10\/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial. Bone Marrow Transplant. 2022;57:1573\u201380.","journal-title":"Bone Marrow Transplant"},{"key":"3024_CR11","first-page":"2965","volume":"110","author":"Z-L Xu","year":"2025","unstructured":"Xu Z-L, Han T-T, Zhu X-L, Liu J, Lv M, Sun Y-Q, et al. Randomized trial of anti-thymocyte globulin plus lowdose post-transplant cyclophosphamide to prevent graft-versus- host disease in haploidentical transplantation. Haematologica. 2025;110:2965\u201373.","journal-title":"Haematologica"},{"key":"3024_CR12","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/s41409-022-01816-1","volume":"57","author":"A Spyridonidis","year":"2022","unstructured":"Spyridonidis A, Labopin M, Brissot E, Moiseev I, Cornelissen J, Choi G, et al. Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplant. 2022;57:1774\u201380.","journal-title":"Bone Marrow Transplant"},{"key":"3024_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41409-017-0053-9","volume":"53","author":"U Deotare","year":"2018","unstructured":"Deotare U, Atenafu EG, Loach D, Michelis FV, Kim DD-H, Thyagu S, et al. Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation. Bone Marrow Transplant. 2018;53:361\u20135.","journal-title":"Bone Marrow Transplant"},{"key":"3024_CR14","doi-asserted-by":"publisher","first-page":"536.e1","DOI":"10.1016\/j.jtct.2024.01.075","volume":"30","author":"MQ Salas","year":"2024","unstructured":"Salas MQ, Alfaro-Moya T, Atenafu EG, Datt Law A, Lam W, Pasic I, et al. Outcomes of antithymocyte globulin-post-transplantation cyclophosphamide-cyclosporine-based versus antithymocyte globulin-based prophylaxis for 10\/10 HLA-matched unrelated donor allogeneic hematopoietic cell transplantation. Transplant Cell Ther. 2024;30:536.e1\u201313.","journal-title":"Transplant Cell Ther"},{"key":"3024_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MOH.0000000000000882","volume":"32","author":"F Barriga","year":"2025","unstructured":"Barriga F. Antithymocyte globulin and posttransplant cyclophosphamide in graft vs. host disease prophylaxis: comparison or combination. Curr Opin Hematol. 2025;32:301\u20137.","journal-title":"Curr Opin Hematol"},{"key":"3024_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jtct.2025.10.038","volume":"32","author":"H Chen","year":"2026","unstructured":"Chen H, Zhang Y, Fan Y, Liu Q, Min W, Xia L, et al. Exploration of in vivo T-cell depletion protocols in allogeneic hematopoietic stem cell transplantation for hematological malignancies. Transplant Cell Ther. 2026;32:412\u201327.","journal-title":"Transplant Cell Ther"},{"key":"3024_CR17","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0197-2456(02)00242-8","volume":"23","author":"NW Scott","year":"2002","unstructured":"Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials. a review. Control Clin Trials. 2002;23:662\u201374.","journal-title":"Control Clin Trials"},{"key":"3024_CR18","doi-asserted-by":"crossref","unstructured":"Elsawy M, Storer BE, Milano F, Sandmaier BM, Delaney C, Salit RB, et al. Prognostic performance of the augmented hematopoietic cell transplantation-specific comorbidity\/age index in recipients of allogeneic hematopoietic stem cell transplantation from alternative graft sources. Biol Blood Marrow Transplant. 2018;25:1045\u201352.","DOI":"10.1016\/j.bbmt.2018.11.030"},{"key":"3024_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","volume":"22","author":"AC Harris","year":"2016","unstructured":"Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount sinai acute GVHD International Consortium. Biol Blood Marrow Transplant. 2016;22:4\u201310.","journal-title":"Biol Blood Marrow Transplant"},{"key":"3024_CR20","doi-asserted-by":"crossref","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. 2014;21:389\u2013401.","DOI":"10.1016\/j.bbmt.2014.12.001"},{"key":"3024_CR21","doi-asserted-by":"crossref","unstructured":"Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ 2016;355.","DOI":"10.1136\/bmj.i5239"},{"key":"3024_CR22","first-page":"10","volume":"13","author":"Y Zu","year":"2023","unstructured":"Zu Y, Gui R, Li Z, Wang J, Zhang Y, Yu F, et al. Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial. Blood. Cancer J. 2023;13:10.","journal-title":"Cancer J"},{"key":"3024_CR23","doi-asserted-by":"crossref","unstructured":"DeZern A, Zahurak ML, Symons HJ, Cooke KR, Huff CA, Jain T, et al. Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia. Blood J Am Soc Hematol. 2023;141:3031\u20138.","DOI":"10.1182\/blood.2023020435"},{"key":"3024_CR24","doi-asserted-by":"publisher","first-page":"101080","DOI":"10.1016\/j.blre.2023.101080","volume":"62","author":"R Dul\u00e9ry","year":"2023","unstructured":"Dul\u00e9ry R, Brissot E, Mohty M. Combining post-transplant cyclophosphamide with antithymocyte globulin for graft-versus-host disease prophylaxis in hematological malignancies. Blood Rev. 2023;62:101080.","journal-title":"Blood Rev"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03024-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03024-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03024-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:41Z","timestamp":1793978861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-03024-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3024"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-03024-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8949910\/v1","asserted-by":"object"}]},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors received research funds from Sanofi, either directly or indirectly. There are no other relevant disclosures.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the following ethics committees representing all participating centres: St Vincent\u2019s Hospital, Melbourne Human Research Ethics Committee[Sydney centres (2)HREC005\/21]; Comit\u00e9 d'\u00e9thique de la recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval[2021-5221]; University of Manitoba Health Research Ethics Board[B2020:074]; Nova Scotia Health Research Ethics Board[1025718]; University of Saskatchewan, Biomedical Research Ethics Board[2183]; Ontario Cancer Research Ethics Board [Hamilton and London 1852]; University of British Columbia Research Ethics Board[H22-03310]; Conjoint Health Research Ethics Board, University of Calgary[REB15-1143] Written informed consent was obtained from all participants prior to their enrollment in the study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}